Description
Dabrafenib is a kinase inhibitor designed to treat cancers with a specific gene mutation called “BRAF V600”.
It is primarily used to treat metastatic melanoma, non-small cell lung cancer, and anaplastic thyroid cancer.
It works by targeting and blocking the BRAF protein, which signals cancer cells to grow and divide.
It is frequently prescribed in combination with Trametinib (Mekinist) for enhanced effectiveness.
达拉非尼是一种激酶抑制剂,旨在治疗具有特定基因突变(称为“BRAF V600”)的癌症。它主要用于治疗转移性黑色素瘤、非小细胞肺癌和间变性甲状腺癌。它通过靶向并阻断 BRAF 蛋白发挥作用,该蛋白负责向癌细胞发送生长和分裂的信号。它通常与曲美替尼(迈吉宁)联合使用,以增强疗效。
Dosage: 75mg per capsule (每粒含 75mg).
Quantity: 120 capsules per bottle (120粒/瓶).
Manufacturer: Novartis (诺华).


Reviews
There are no reviews yet.